GC Aesthetics
- Company typePrivate
- Founded2007
- HeadquartersSandyford, Ireland
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What GC Aesthetics does
GC Aesthetics (GCA) is a privately-held Irish medical technology company that designs, manufactures, and markets silicone breast implants and complementary surgical solutions for aesthetic and reconstructive breast surgery. Founded in 2007 through the consolidation of legacy brands Nagor and Eurosilicone, the company operates from headquarters in Dublin, Ireland, with ISO-certified manufacturing facilities in Cumbernauld, Scotland and Apt, France, and has sold more than 3 million implants across 70+ countries. Its product portfolio spans core breast implant brands (PERLE, Luna XT, The Round Collection, Adora), reconstruction devices (FixNip NRI, Blossom IVTE tissue expanders), and the Puregraft fat transfer system acquired through the OPALINE Aesthetics joint venture with Bimini Health Tech, with proprietary technology including BioQ surface treatment and Emunomic dynamic gel.
The business sells B2B exclusively to board-certified plastic surgeons and hospitals through a hybrid model of direct field sales in major European markets and exclusive distribution partners in LATAM, China, and other regions, with surgeon engagement driven by platinum and diamond sponsorships at major breast surgery conferences (ISAPS, SOFCEP, Barcelona Breast Meeting) and the GCA Academy training platform. The company's GTM motion also includes an online surgeon directory, direct-to-patient content marketing, and a branded e-commerce shop for post-surgery accessories. Products are differentiated by published 10-year prospective clinical safety data, the only implant approved under the latest European Medical Device Regulation (Luna XT), and the GCA Comfort Plus lifetime warranty covering rupture, capsular contracture, and BIA-ALCL. Pricing is not publicly disclosed, and revenue figures are not released; ownership is backed by Hayfin Capital Management, with operations led by CEO Carlos Reis Pinto and an expanded board including Chairman Luigi Ferrari.
Revenue is generated through hardware sales of implants and surgical devices plus adjacent services such as the GCA Comfort Plus warranty, GCA Academy training, and the post-surgery consumer e-commerce shop. The company is pursuing a clear expansion agenda into China, deeper LATAM penetration, and US market access via the OPALINE joint venture, supported by ongoing product launches (Adora, YOUTHLY) and regulatory first-mover positioning under the European MDR.
GC Aesthetics firmographics
Firmographics- Name
- GC Aesthetics
- Legal name
- GC Aesthetics, Ltd.
- Website
- https://gcaesthetics.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
GC Aesthetics industry classification
Industry- Product category
- Medical Aesthetic Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)
- akta.pro secondary industry
- Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)
Keywords
Where GC Aesthetics is headquartered
LocationHeadquarters
- HQ city
- Sandyford
- HQ country
- Ireland
- HQ region
- Europe
Offices3 records
Markets served
GC Aesthetics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Breast Implant Sales: Sale of silicone breast implants and medical devices to plastic surgeons and hospitals for aesthetic and reconstructive procedures
- Surgical Solutions Portfolio: Sale of complementary surgical products including tissue expanders (Blossom™), wound care (Healena™), fat transfer systems (Puregraft®), and nipple reconstruction implants (FixNip™ NRI)
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
GC Aesthetics product offering
Product offeringCore offering
GC Aesthetics designs, develops, manufactures and markets silicone breast implants and complementary surgical solutions for aesthetic and reconstructive breast surgery. The portfolio spans round and anatomical implants, tissue expanders, fat transfer systems, nipple reconstruction implants, wound healing, and 3D/AR surgical planning tools, sold exclusively to board-certified plastic surgeons and hospitals across 70+ countries.
Product overview
GC Aesthetics® is a comprehensive medical aesthetics company offering a broad portfolio of breast implants and surgical solutions for aesthetic and reconstructive procedures. The product lineup centers on five core breast implant brands: PERLE™ (smooth round with BioQ™ technology), Luna XT™ (MDR-compliant anatomical), The Round Collection™ (textured/smooth round options), and Adora™ (micro-textured), all supported by published 10-year clinical data. The reconstruction portfolio includes FixNip™ NRI for nipple-areola reconstruction, Blossom™ IVTE tissue expander, and Puregraft® for fat transfer. Supporting tools include HydroCone™ for complication management, Eve 4.0™ 3D/AR simulation powered by Crisalix®, The Consultation Kit™, and Noa™ postoperative bra. All products are backed by the GCA Comfort Plus™ lifetime warranty and supported by the GCA Academy™ training platform. The company has evolved from its legacy Nagor and Eurosilicone brands into a unified ONE GCA identity, operating manufacturing facilities in Scotland and France with distribution across 70 countries.
Differentiator
Problem solved
Functional benefit
Brands
- PERLE™: Round breast implant with BioQ™ surface technology and Emunomic™ Breast Tissue Dynamic Gel.
- Luna XT™
- Adora™
- The Round Collection™
- FixNip™ NRI
- Puregraft®
- Healena™
- Blossom™ IVTE
- Eve 4.0™
- Noa™
- GCA Academy™
- GCA Comfort Plus™ Warranty
- Total Breast Reconstruction™
Products and services
- PERLE™ Round breast implant with revolutionary BioQ™ surface technology and highly cohesive Emunomic™ Breast Tissue Dynamic Gel, featuring a unique smooth opaque surface for board-certified plastic surgeons performing aesthetic augmentation.
- Luna XT™ First breast implant on the market under the latest Medical Device Regulation (MDR); industry-leading micro-textured anatomical implant for breast reconstruction procedures, for plastic and reconstructive surgeons.
- The Round Collection™ Round breast implants available in microtextured and smooth surface variants, supported by 10-year safety data with four different projections from low to extra-high, for plastic surgeons performing augmentation and reconstruction.
- Adora™ Comprehensive micro-textured breast implant designed for stability, softness, clinical confidence, and surgical versatility in breast augmentation and reconstruction.
- FixNip™ NRI Nipple-areola reconstruction implant providing a minimally invasive solution with lasting projection and natural results for women after breast reconstruction, featuring Nitinol-reinforced silicone construction.
- Blossom™ IVTE Integrated Valve Tissue Expander for temporary subcutaneous implantation, requiring periodic incremental inflation with sterile saline until desired tissue is developed, for staged breast reconstruction.
- Puregraft® Autologous fat transfer system for breast augmentation and reconstruction, enabling graft preparation through dedicated filtration; part of the combined GCA/Bimini portfolio.
- Healena™ Advanced wound healing solution designed to support optimal post-surgical recovery following breast surgery, for use by surgeons and patients.
- HydroCone™ Post-operative device designed to minimize complications when used with all GCA® breast implants, supporting recovery and reducing adverse events.
- Eve 4.0™ 3D planning and simulation tool powered by Crisalix® providing augmented reality breast surgery planning and patient consultation support for plastic surgeons.
- Noa™ Postoperative compression bra for recovery support following breast augmentation or reconstruction surgery.
Quantifiable outcome
- 1.5% overall revision rate at 10 years (independent study of 716 patients)
- +3 more outcomes
Companies that use GC Aesthetics
Customer profileNamed customers4 records
Segments2 records
Ideal customer profiles2 records
GC Aesthetics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability3 records
Feature6 records
GC Aesthetics partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered major, core, strategic and minor.
- G&S Group (China)majorCollaboration to launch YOUTHLY brand in China, offering premium breast implant solutions including Round Collection 100% filled, PERLE, and Luna XT implants manufactured in France and UK.
- Bimini Health TechcoreJoint venture partnership creating 'OPALINE Aesthetics' to revolutionize breast reconstruction globally. GC Aesthetics deploys Bimini's healthcare solutions outside US and Canada; Bimini commercializes selective GCA reconstruction solutions in US to complement Puregraft portfolio. Combined expertise in design, manufacturing, and reconstruction innovation.
- Grupo Venta Internacional (GVI)majorExclusive distributor for Mexico market, collaborating on AMCPER International Congress participation and LATAM market expansion.
- Puregraft (Bimini subsidiary)corePuregraft adipose filtration system for autologous fat transfer procedures now part of combined portfolio through Bimini partnership.
- ISAPS (International Society of Aesthetic Plastic Surgery)strategicGC Aesthetics is a sponsor of ISAPS, the leading professional society for aesthetic plastic surgeons globally.
- Komen ItaliaminorPartnership supporting Total Breast Reconstruction program in Italy for breast cancer survivors.
- Medicorp (Chile)majorDistribution partner in Chile facilitating first FixNip NRI surgery milestone in the country.
Scale indicators9 records
Recent moves9 records
Expansion highlights6 records
GC Aesthetics competitors and assessment
Company assessmentBroad incumbents
- Mentor (Johnson & Johnson): Johnson & Johnson's breast aesthetics business is the largest and most established silicone and saline breast implant manufacturer globally. Directly competes with GCA across implant categories, surgeon relationships, and warranty programs, with significantly greater commercial scale.
- Allergan Aesthetics (AbbVie): AbbVie division that markets Natrelle breast implants and is one of the dominant global breast implant brands. Direct competitor across the full breast aesthetic and reconstructive portfolio, with a much larger sales force and global footprint.
Direct peers
- Establishment Labs: Public breast implant company (Motiva brand) competing head-to-head with GCA in aesthetic and reconstruction segments. Particularly aggressive in expanding US share and in innovation around smooth surfaces and ergonomix designs.
- Sientra: US-focused breast implant company with portfolio overlapping GCA's PERLE and Luna XT. Direct competitor in aesthetic and reconstructive surgery, focused on US market expansion and premium surgeon channels.
- POLYTECH Health & Aesthetics: German-based breast implant and soft-tissue implant manufacturer. Closest European mid-sized competitor to GCA, with overlapping implant lines, reconstruction devices, and distribution across Europe, LATAM, and Asia.
- Sebbin: French breast implant manufacturer serving European, LATAM, and select Asian markets. Directly comparable product portfolio (silicone breast implants, expanders) competing in GCA's core European markets and similar regulatory and surgeon-loyalty dynamics.
Emerging players
- HansBiomed: Korean medical device company expanding in breast implants and tissue regeneration. Comparable in size and product scope to GCA but with stronger APAC distribution, and emerging presence in Europe and LATAM.
Others
- Bimini Health Tech: Partner in the OPALINE Aesthetics JV; Puregraft and reconstructive solutions provider. Strategic partner and partial competitor in select reconstruction segments, especially relevant given the JV commercial structure.
- Crisalix: 3D/AR simulation platform powering GCA's Eve 4.0 tool. Enabling technology peer used across breast implant manufacturers; useful for comparing surgeon-engagement and digital-surgical-planning economics in the category.
Regional players
- Motiva USA / Establishment Labs (US operations): US commercial arm of Establishment Labs focused on direct-to-surgeon aesthetic implant sales. Relevant as the principal disruptor in GCA's largest whitespace (US aesthetics) where GCA relies on its Bimini JV.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
GC Aesthetics social profiles
Digital presenceGC Aesthetics compliance and trust
Trust signalCompliance6 records
GC Aesthetics financial estimates
Financial estimateRevenue estimate
Valuation estimate
GC Aesthetics leadership team
Management profileNumber of profiles
Profiles13 records
GC Aesthetics subsidiaries and ownership
Company hierarchySubsidiaries1 record
GC Aesthetics funding detail
Funding detailFunding overview
Funding rounds4 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GC Aesthetics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GC Aesthetics
What does GC Aesthetics do?
GC Aesthetics designs, develops, manufactures and markets silicone breast implants and complementary surgical solutions for aesthetic and reconstructive breast surgery. The portfolio spans round and anatomical implants, tissue expanders, fat transfer systems, nipple reconstruction implants, wound healing, and 3D/AR surgical planning tools, sold exclusively to board-certified plastic surgeons and hospitals across 70+ countries.
Is GC Aesthetics a public or private company?
GC Aesthetics is a private company. It is classified as private equity controlled and is currently operating.
When was GC Aesthetics founded?
GC Aesthetics was founded in 2007. It employs 251 to 500 people.
Where is GC Aesthetics based?
GC Aesthetics is headquartered in Sandyford, Ireland, in the Europe region.
How does GC Aesthetics make money?
Two revenue lines are on record. Breast Implant Sales are the primary driver. The others are surgical Solutions Portfolio.
Who are GC Aesthetics's main competitors?
Broad incumbents on record are Mentor (Johnson & Johnson) and Allergan Aesthetics (AbbVie). Direct peers are Establishment Labs, Sientra, POLYTECH Health & Aesthetics and Sebbin. HansBiomed is listed as an emerging player. Others are Bimini Health Tech and Crisalix. Motiva USA / Establishment Labs (US operations) is listed as a regional player.
Does GC Aesthetics have an API?
No public API is recorded for GC Aesthetics.
What industry is GC Aesthetics in?
GC Aesthetics's product category is Medical Aesthetic Devices. Its primary akta.pro industry code is HLAHADAM, Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits), with a secondary code of HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS). Its NAICS code is 339113 and its SIC code is 3841.